The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...
The panel focused on the provisions of the Inflation Reduction Act that aim to lower prescription drug prices under Medicare.
Seniors in metro Detroit and across Michigan have an opportunity to sign up for the right Medicare plan during open ...
The U.S. pharmaceutical industry is attempting to delay the timeline for Medicare's drug price negotiations following the ...
The Inflation Reduction Act (the Act) of 2022 was controversial at the time the Act was signed into law and remains so. To date, multiple ...
With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.
Congress recently made a number of changes to Medicare's "Part D" prescription drug benefit. The changes were part of ...
The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...
The Biden administration's proposed rule could expand coverage of anti-obesity medications for Medicare and Medicaid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback